Scarica l'app Stockscreener
15.99
2.62%
-0.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$16.42
Aprire:
$16.36
Volume 24 ore:
764.62K
Relative Volume:
0.59
Capitalizzazione di mercato:
$735.74M
Reddito:
$203.27M
Utile/perdita netta:
$-4.66M
Rapporto P/E:
-159.90
EPS:
-0.1
Flusso di cassa netto:
$3.47M
1 W Prestazione:
-10.57%
1M Prestazione:
-0.50%
6M Prestazione:
+1.20%
1 anno Prestazione:
+17.57%
Intervallo 1D:
$15.63
$16.49
Intervallo di 1 settimana:
$15.63
$18.04
Portata 52W:
$9.215
$21.00
Axogen Inc Stock (AXGN) Company Profile
Nome
Axogen Inc
Settore
Industria
Telefono
(386) 462-6817
Indirizzo
13631 PROGRESS BLVD., ALACHUA, FL
Confronta AXGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
15.99 | 755.53M | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-17 | Iniziato | Lake Street | Buy |
| 2024-07-01 | Iniziato | Raymond James | Outperform |
| 2022-11-11 | Ripresa | Jefferies | Buy |
| 2022-05-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | Guggenheim | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Iniziato | Canaccord Genuity | Buy |
| 2018-03-02 | Reiterato | Lake Street | Buy |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Iniziato | Jefferies | Buy |
| 2017-11-21 | Reiterato | Lake Street | Buy |
| 2017-07-31 | Iniziato | Leerink Partners | Outperform |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Iniziato | ROTH Capital | Buy |
| 2016-11-22 | Aggiornamento | Lake Street | Hold → Buy |
| 2016-11-07 | Reiterato | Wedbush | Outperform |
| 2016-11-03 | Downgrade | Lake Street | Buy → Hold |
| 2016-08-04 | Reiterato | Wedbush | Outperform |
| 2014-05-14 | Iniziato | Dawson James | Buy |
| 2013-10-31 | Reiterato | Ladenburg Thalmann | Buy |
Mostra tutto
Axogen Inc Borsa (AXGN) Ultime notizie
What’s next for Axogen Inc. stock priceWeekly Trend Summary & Advanced Swing Trade Entry Alerts - newser.com
Can Axogen Inc. stock continue upward trendLayoff News & Fast Momentum Entry Tips - newser.com
Visual analytics tools that track Axogen Inc. performance2025 Investor Takeaways & Daily Stock Trend Watchlist - newser.com
Will Axogen Inc. stock deliver strong dividend growthGlobal Markets & Real-Time Stock Entry Alerts - newser.com
Predicting Axogen Inc. trend using moving averages2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Axogen, Inc. (AXGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Volume spikes in Axogen Inc. stock – what they meanLong Setup & Fast Exit/Entry Strategy Plans - newser.com
AxoGen (NASDAQ:AXGN) Stock Price Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat
Real time social sentiment graph for Axogen Inc.Stock Surge & Free Safe Entry Trade Signal Reports - newser.com
Why Axogen Inc. is moving today2025 Market Outlook & Reliable Breakout Forecasts - newser.com
How sentiment analysis helps forecast Axogen Inc.Portfolio Update Report & Verified Momentum Watchlists - newser.com
Can Axogen Inc. stock weather global recessionJuly 2025 Decliners & Low Risk High Reward Ideas - newser.com
AxoGen's (AXGN) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Market reaction to Axogen Inc.’s recent newsQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc.AXGN - WV News
Axogen, Inc. Experiences Evaluation Revision Amidst Shifting Market Dynamics and Performance Indicators - Markets Mojo
Insider Sell: Burke William P. Mr. Sells Shares of Axogen Inc (A - GuruFocus
William Mr. Burke Sells 736 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
William Mr. Burke Sells 14,571 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $137,236.20 in Stock - MarketBeat
Axogen Director William P. Burke Sells Over 32,000 Shares - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Axogen, Inc. (AXGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
How to recover losses in Axogen Inc. stockJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Is FDA Review Delay and Legal Scrutiny Altering the Investment Case for Axogen (AXGN)? - Sahm
A Look at Axogen (AXGN) Valuation Following FDA Avance Delay and Securities Law Probe - Yahoo Finance
AxoGen, Inc. (NASDAQ:AXGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Axogen, Inc. (AXGN) And Encourages Stockholders to Reach Out - ACCESS Newswire
Combining price and volume data for Axogen Inc.Trend Reversal & Safe Investment Capital Preservation Plans - newser.com
HighMark Wealth Management LLC Has $1.06 Million Position in AxoGen, Inc. $AXGN - MarketBeat
Equities Analysts Issue Forecasts for AxoGen Q3 Earnings - MarketBeat
FDA Extends Review for AxoGen’s Avance Nerve Graft - MSN
Canaccord Genuity reiterates Buy rating on AxoGen stock, citing BLA approval potential - Investing.com
AxoGen (NASDAQ:AXGN) Coverage Initiated at HC Wainwright - Defense World
Canaccord Genuity maintains Buy rating on AxoGen stock amid shutdown concerns - Investing.com Nigeria
Axogen, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights – AXGN - MarketScreener
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm - The Globe and Mail
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $24 - 富途牛牛
AxoGen (NASDAQ:AXGN) Now Covered by HC Wainwright - MarketBeat
AxoGen stock rating reiterated as Buy by H.C. Wainwright By Investing.com - Investing.com Nigeria
AxoGen stock rating reiterated as Buy by H.C. Wainwright - Investing.com Nigeria
Axogen Inc Azioni (AXGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Axogen Inc Azioni (AXGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Burke William P. Mr. | Director |
Oct 03 '25 |
Sale |
18.21 |
14,571 |
265,283 |
2,293 |
| Burke William P. Mr. | Director |
Oct 03 '25 |
Sale |
18.21 |
7,600 |
138,367 |
0 |
| Burke William P. Mr. | Director |
Oct 02 '25 |
Sale |
18.01 |
7,620 |
137,200 |
16,864 |
| Burke William P. Mr. | Director |
Oct 02 '25 |
Sale |
18.01 |
2,400 |
43,224 |
7,600 |
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):